BPC-157: Handling, Storage, and Reconstitution Guide

This guide covers lab handling, storage, and reconstitution of BPC-157 as a lyophilized research peptide. Lyophilized means freeze-dried. Every step below is lab best practice for in-vitro and animal-model preparation. None of it is instruction for human use.

How should BPC-157 be stored?

Store lyophilized BPC-157 sealed, at or below 25 degrees Celsius, away from heat, light, and moisture. It ships as a solid white powder in a sealed glass vial. For long storage, keep it freeze-dried and refrigerated or frozen. The peptide is reported to be stable, which helps. Still, steady storage protects its quality across a study.

Puritide supplies BPC-157 in 5 mg, 10 mg, and 20 mg vials. The working-stock concentration depends on how much diluent is added to the labeled mass.

Stability makes BPC-157 easier to handle. It does not remove the need for careful storage. Even a robust peptide breaks down faster with repeated warming and cooling. Moisture speeds this up too. So the same cold-chain and low-humidity habits used for fragile peptides still apply. They still protect data quality.

Why confirm the BPC-157 peptide form first?

BPC-157 comes in two forms with different weights, so the form must be known before any math. The two forms are the free acid and the acetate salt.

• Free acid: about 1419.5 g/mol, CAS 137525-51-0
• Acetate salt: about 1479.6 g/mol, CAS 216441-37-1

Peptide products are often supplied as the acetate salt. So confirm the form on the certificate of analysis before you calculate concentrations. Getting this right is key for the quantitative work in the BPC-157 research applications.

How is BPC-157 reconstituted for in-vitro work?

Reconstitute BPC-157 with bacteriostatic water or another solvent that suits the assay. Add the diluent slowly down the inside wall of the vial. Do not pour it right onto the powder. Let the peptide dissolve gently. Swirl the vial. Do not shake it or vortex it hard. Rough mixing can shear the peptide and cause foam.

• Add diluent against the vial wall, not onto the pellet.
• Let it dissolve gently, without rough mixing.
• Check that it has fully dissolved before use.
• Work out concentration from labeled mass, diluent volume, and peptide form.

Why aliquot BPC-157 after reconstitution?

Aliquoting limits freeze-thaw cycles, which protects the peptide. Split the reconstituted BPC-157 into single-use portions, called aliquots. Then each experiment uses a vial that has been thawed only once. Label each aliquot with:

• Compound name
• Concentration
• Date
• Lot number
• Peptide form

Fewer freeze-thaw cycles keep exposure steady. Repair and cell-protection assays depend on that. The same practice appears in the TB-500 handling guide.

How should reconstituted BPC-157 be kept cold?

Freeze reconstituted aliquots for longer holds. Keep short-term working solutions cold and away from light. Hold conditions steady for the whole study. Check storage records as part of quality control. Logging time at each temperature supports repeatable results and audits.

What does the BPC-157 certificate of analysis show?

Each BPC-157 batch ships with a certificate of analysis, or COA, checked by a third party. It documents:

• Purity, by HPLC (reverse-phase chromatography)
• Identity, confirmed by mass spectrometry
• Lot, test date, and method details

Check the COA against the vial label. Confirm the peptide form. Keep the document with your batch records. Sample COAs can be requested before purchase.

What safety steps apply when handling BPC-157?

Handle BPC-157 as an investigational material. Follow your institution's rules:

• Standard operating procedures and chemical hygiene plans
• Approved protocols
• A lab coat, gloves, and eye protection
• Engineering controls where required

Only trained staff should handle it, in controlled settings. The BPC-157 mechanism of action and the BPC-157 product page give the specifications needed for checks.

At intake, match the vial to its recorded names. Confirm the expected white freeze-dried look. Then check the salt form, so the concentration math is right from the start. BPC-157 is used very widely. A steady intake-check habit is one of the easiest ways to keep results comparable. That holds across studies and across the vial sizes offered.

How should labs document several BPC-157 vial sizes?

BPC-157 comes in several vial sizes, so shared records prevent mix-ups. Each preparation record should capture:

• The vial size
• The peptide form
• The diluent volume
• The resulting concentration

Then stocks made from a 5 mg vial are never confused with those from a 20 mg vial. This is simple, but easy to miss when several batches are in use at once.

Keeping the certificate of analysis with each record closes the loop. Say a later experiment gives a surprising result. The records let labs check whether the material, its form, or its concentration could explain it. The preparation does not become an untracked variable.

In the end, steady handling is a reproducibility measure. A good BPC-157 batch is checked against its COA and reconstituted gently. It is aliquoted to limit freeze-thaw and kept under stable cold-chain conditions. It is also fully documented. That gives every later experiment the same reliable starting material. Other labs can then compare results and build on each other's work.

Sometimes a study proves hard to repeat. A complete handling record often lets labs tell a real biological difference from a preparation error. That is why careful BPC-157 handling pays off across a project.

For research use only. These handling notes describe laboratory practice for BPC-157 as a research material supplied by Puritide Research. BPC-157 is not approved for human or veterinary use, and nothing here constitutes medical or administration guidance.